5paisa Q1: revenue +14% YoY, consolidated PAT flat at ₹11.6 Cr as margins compress
PAT +0.18% YoY · revenue +13.7% · margins compressing
₹88.33 Cr
+13.7% YoY
₹11.57 Cr
+0.18% YoY
13.09%
-1.8pp YoY
₹2.6
5paisa Capital's consolidated Q1 FY27 (quarter ended June 30, 2026) print was a growth-without-operating-leverage quarter: revenue from operations rose 13.7% YoY to ₹88.33 Cr, but net profit was essentially flat at ₹11.57 Cr versus ₹11.55 Cr a year ago (+0.2%). The topline was carried by interest income, up 26.5% YoY to ₹42.17 Cr as the company began deploying rights-issue capital into its MTF/funding book; fees and commission income grew a softer 4.1% to ₹46.16 Cr, pointing to muted brokerage momentum. The disconnect between double-digit revenue growth and flat profit sits in costs — other expenses jumped ~25% YoY to ₹40.17 Cr — dragging net margin down to 13.1% from 14.85% a year earlier (though up sequentially from 12.7% in Q4). Management's own annexure pegs operating margin at 17% and NPM at 13%.
Q1 FY-2027 vs prior quarters
The standout for shareholders is EPS: basic EPS fell to ₹2.60 from ₹3.70 YoY despite flat PAT, purely a dilution effect from the ₹468.82 Cr rights issue that lifted the share count ~50% (paid-up capital ₹31.25 Cr → ₹46.88 Cr). This is the first full quarter reflecting that expanded base. On QoQ terms revenue rose 3.4% and PAT 6.6% off the March quarter, but the year-on-year comparison — flat profit on 14% higher revenue — is the honest read.
The stock went into the print at ₹384, up 17.1% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
Standalone near-identical — PAT ₹11.50 Cr on revenue ₹88.33 Cr, EPS ₹2.58 — subsidiaries immaterial
Management provided strategic guidance centered on deploying the recently raised INR 468 crores from its successful rights issue to fuel long-term growth. Capital is earmarked for supporting higher trading volumes, significantly expanding the MTF funding book, and funding core business expansion through investments in
Against prior guidance, management gave no quantitative targets on the Q4 concall, only a qualitative plan to deploy the ₹468 Cr raise into higher trading volumes, a larger MTF book, and tech/AI investment; this quarter's 26.5% jump in interest income is directionally consistent with that, but the promised growth has not yet reached the bottom line. No street consensus is available for this small-cap. Two regulatory overhangs bracket the print: the ₹33.02 Cr income-tax demand (under CIT(A) appeal, not provisioned) and a June-2026 SEBI show-cause notice on Investment Adviser registration. There is no management press release on record for this result.
What to watch
W1
MTF/funding book scale-up: interest income at ₹42.17 Cr (+26.5% YoY) is the growth driver post rights issue — watch if it sustains and starts converting to profit
W2
Margin trajectory: NPM 13.1% vs 14.85% YoY, with other expenses +25% YoY — verify whether cost growth continues to erode margins next quarter
W3
₹33.02 Cr income-tax demand — outcome of the CIT(A) appeal and any provisioning; plus the June-2026 SEBI show-cause notice on Investment Adviser registration
Clean digital PDF, ₹ in lacs. No exceptional items in either period. ₹33.02 Cr income-tax demand (Jan-2025 search, block period FY19-FY25) flagged as Emphasis of Matter — under CIT(A) appeal, NOT booked in P&L. EPS fell YoY due to ~50% share-count rise from the ₹468.82 Cr rights issue (capital ₹31.25→₹46.88 Cr). Consolidated and standalone virtually identical (subsidiaries negligible).
Informational and educational content only. Not investment advice.